Home > Category > > Small Molecule Compound > H-Arg-Lys-OH TFA

H-Arg-Lys-OH TFA

Glpbio

Catalog No：GC38587-1mg CAS No.： MDLNo： Brand:Glpbio purity： 特性： Purpose:H-Arg-Lys-OH TFA 是由 L-精氨酸和 L-赖氨酸残基形成的二肽。H2O: 250 mg/mL (600.38 mM)

Share

Size	Availability	Price(USD)
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	H-Arg-Lys-OH TFA
Formula	C₁₄H₂₇F₃N₆O₅
MW	416.4
Storage condition	Store at -20°C

Related literature

Sorry, there is no relevant literature

Related

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

History

(11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

NA ≥98%,99%e.e.

H-Arg-Lys-OH TFA

H-Arg-Lys-OH TFA

(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

NA ≥98%,99%e.e.

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

1585988-92-6 ≥98%,99%e.e.

(11aS)-3,7-Bis(2,4,6-trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-3,7-Bis(2,4,6-trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

NA ≥98%,99%e.e.

KV1.1 (KCNA1) (EXTRACELLULAR)

KV1.1 (KCNA1) (EXTRACELLULAR)

(8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin

(8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin

871130-17-5 ≥98%,99%e.e.

(R)-N,N'-Dimethyl-1,1'-binaphthyldiamine

(R)-N,N'-Dimethyl-1,1'-binaphthyldiamine

93713-30-5 ≥98%,99%e.e.

WIN site inhibitor 1 TFA

WIN site inhibitor 1 TFA

BMVC-8C3O